Progressive supranuclear palsy with marked ventricular dilatation mimicking normal pressure hydrocephalus

Background Progressive supranuclear palsy (PSP) patients can show ventricular enlargement mimicking normal pressure hydrocephalus (NPH). The aim of this study was to distinguish PSP patients with marked ventricular dilatation (PSP-vd) from those with normal ventricular system and to evaluate the coe...

Full description

Saved in:
Bibliographic Details
Published inNeurological sciences Vol. 43; no. 3; pp. 1783 - 1790
Main Authors Quattrone, Andrea, Sarica, Alessia, La Torre, Domenico, Morelli, Maurizio, Mechelli, Alessandro, Arcuri, Pier Paolo, Quattrone, Aldo
Format Journal Article
LanguageEnglish
Published Cham Springer International Publishing 01.03.2022
Springer Nature B.V
Subjects
Online AccessGet full text
ISSN1590-1874
1590-3478
1590-3478
DOI10.1007/s10072-021-05594-4

Cover

More Information
Summary:Background Progressive supranuclear palsy (PSP) patients can show ventricular enlargement mimicking normal pressure hydrocephalus (NPH). The aim of this study was to distinguish PSP patients with marked ventricular dilatation (PSP-vd) from those with normal ventricular system and to evaluate the coexistence of NPH in PSP-vd patients. Methods One hundred three probable PSP patients, 18 definite NPH patients, and 41 control subjects were enrolled in the study. Evans index (EI) > 0.32 associated with callosal angle (CA) < 100° was used to identify PSP-vd patients. Automated ventricular volumetry (AVV) and Magnetic Resonance Hydrocephalic Index (MRHI) were performed on T1-weighted MR images to evaluate the presence of NPH in PSP-vd patients. Results Twelve (11.6%) out of 103 PSP patients had both abnormal EI and CA values (PSP-vd). In two of these 12 patients, AVV and MRHI values suggested PSP + NPH. In the remaining 10 PSP-vd patients, AVV and MRHI values were higher than PSP patients with normal ventricular system and controls, but lower than PSP + NPH and NPH patients, suggesting a non-hydrocephalic ventricular enlargement. Discussion Our study provides evidence that the combination of EI and CA biomarkers allowed to identify PSP patients with marked ventricular dilatation mimicking NPH. Only a few of these patients had PSP + NPH. Recognition of these PSP patients with enlarged ventricles can positively impact the care of this disease, helping clinicians to identify patients with PSP + NPH who could benefit from shunt procedure and avoid surgery in those with enlarged ventricles without NPH.
Bibliography:ObjectType-Article-1
SourceType-Scholarly Journals-1
ObjectType-Feature-2
content type line 14
content type line 23
ISSN:1590-1874
1590-3478
1590-3478
DOI:10.1007/s10072-021-05594-4